Broad Institute at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Broad Institute brings 1 presentation to ESGCT 2026 in Hamburg. Its program covers in vivo gene therapy for the brain and the translation of adeno-associated virus vectors. It includes progress toward a one-time treatment that silences the prion protein across the brain.
| Organization | ESGCT 2026 Attendance |
|---|---|
Broad Institute Cambridge, MA | |
Harvard and MIT research institute where base and prime editing were developed; its groups also engineer AAV capsids. | Chair Wed Oct 28 8:30am–10:30am SESSION 3b: Hematopoietic & PID Rare and inherited disease Talk Wed Oct 28 4:30pm–5:30pm Progress towards a one-time, brainwide PrP silencing therapy for prion disease Rare and inherited diseaseVectors and delivery (AAV, lentiviral, LNP) Chair Fri Oct 30 11:00am–1:00pm SESSION 12a: AAVs/non integrative vectors III - Translation Vectors and delivery (AAV, lentiviral, LNP)Clinical trials and translation |
Instantly find 20 buyers from Broad Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction